Literature DB >> 30451649

Hepatitis C virus intrinsic molecular determinants may contribute to the development of cholestatic hepatitis after liver transplantation.

Martina Gambato1,2,3, Josep Gregori4,5, Josep Quer4, George Koutsoudakis1, Patricia González1, Noelia Caro-Pérez1,6, Damir García-Cehic4, Neris García-González7, Fernando González-Candelas7, Juan Ignacio Esteban4, Gonzalo Crespo1, Miquel Navasa1, Xavier Forns1, Sofía Pérez-Del-Pulgar1.   

Abstract

Cholestatic hepatitis C (CHC) is a severe form of hepatitis C virus (HCV) infection recurrence that leads to high graft loss rates early after liver transplantation (LT). To investigate the pathogenic mechanisms of CHC, we analysed HCV quasispecies in CHC patients compared to a control group (mild hepatitis C recurrence) by deep pyrosequencing. At the time of LT, NS5B quasispecies complexity was similar between the two groups but, after LT, it decreased more sharply in CHC patients than in the control group. Interestingly, the major variant before LT propagated efficiently and remained as the dominant sequence after LT in 62 % of CHC patients versus 11 % of controls (P=0.031). Sequence analysis of the complete non-structural region in a limited number of patients revealed a potential 12 aa signature specific to the CHC group. These data suggest that intrinsic molecular determinants in the circulating HCV quasispecies may provide a fitness advantage, contributing to the development of CHC.

Entities:  

Keywords:  cholestatic hepatitis C; deep sequencing; hepatitis C virus; liver transplantation; quasispecies

Mesh:

Substances:

Year:  2018        PMID: 30451649     DOI: 10.1099/jgv.0.001175

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  1 in total

1.  Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients.

Authors:  Meritxell Llorens-Revull; Josep Gregori; Cristina Dopazo; Francisco Rodriguez-Frías; Damir Garcia-Cehic; Maria Eugenia Soria; Qian Chen; Ariadna Rando; Celia Perales; Juan Ignacio Esteban; Josep Quer; Itxarone Bilbao
Journal:  Genes (Basel)       Date:  2021-10-28       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.